A detailed history of Dlk Investment Management, LLC transactions in Spero Therapeutics, Inc. stock. As of the latest transaction made, Dlk Investment Management, LLC holds 31,355 shares of SPRO stock, worth $41,388. This represents 0.02% of its overall portfolio holdings.

Number of Shares
31,355
Previous 31,355 -0.0%
Holding current value
$41,388
Previous $40.8 Million 3.08%
% of portfolio
0.02%
Previous 0.02%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Apr 09, 2024

BUY
$1.0 - $1.47 $31,355 - $46,091
31,355 New
31,355 $46.1 Million

Others Institutions Holding SPRO

About Spero Therapeutics, Inc.


  • Ticker SPRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,067,500
  • Market Cap $46.3M
  • Description
  • Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...
More about SPRO
Track This Portfolio

Track Dlk Investment Management, LLC Portfolio

Follow Dlk Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dlk Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dlk Investment Management, LLC with notifications on news.